Business Wire

Amazon Announces Investment in Nature-Based Carbon Removal Solutions in Brazil with The Nature Conservancy

Share

As part of its efforts to support global solutions to the climate crisis, Amazon (NASDAQ: AMZN) today announced the launch of the Agroforestry and Restoration Accelerator in partnership with The Nature Conservancy, a global environmental organization. The Accelerator will create a more sustainable source of income for thousands of local farmers in the Brazilian Amazonian state of Pará, while also restoring native rainforests and fighting climate change by naturally trapping and storing carbon.

According to the Intergovernmental Panel on Climate Change, nature-based solutions have a critical role to play in avoiding the worst effects of climate change. Governments and the private sector can both reduce carbon emissions and remove carbon from the atmosphere by investing in nature-based solutions at scale. The Agroforestry and Restoration Accelerator is one such carbon removal project, and part of Amazon’s commitment to meeting The Climate Pledge, which the company co-founded with Global Optimism. Signatories to the Pledge commit to reaching net-zero carbon by 2040—10 years ahead of the Paris Agreement.

As part of its commitment to meet The Climate Pledge, Amazon is first and foremost continuing to innovate and invest in decarbonizing its businesses. The company has purchased 100,000 electric delivery vehicles, and is the largest corporate buyer of renewable energy in the world. Amazon is also investing in nature-based solutions outside of its value chain through the Right Now Climate Fund, which supports the Accelerator and other projects to restore degraded lands in ways that improve the livelihoods of local communities and remove carbon from the atmosphere. Additionally, through the recently announced LEAF Coalition—a public-private initiative to mobilize at least $1 billion to protect the world’s tropical forests—Amazon and other partners are working to curb tropical deforestation, reducing the amount of carbon emitted in the atmosphere.

“Restoring the world’s forests is one of the most meaningful actions we can take right now to address climate change, and it will require innovative solutions to be successful,” said Kara Hurst, vice president of worldwide sustainability at Amazon. “We are proud to launch the Agroforestry and Restoration Accelerator in partnership with The Nature Conservancy to support solutions that prioritize high environmental integrity and strong community benefits. Amazon is looking forward to contributing our passion for innovation along with financial support to improve the livelihoods of local communities in Brazil, while helping to protect the planet for future generations.”

“Science is unequivocal in regarding natural systems as the priority for absorbing carbon from the atmosphere and the latest IPCC report underscores this,” said Christiana Figueres, co-founder of Global Optimism and former UN climate chief responsible for the Paris Agreement. “Protecting standing ecosystems and restoring degraded land are critical as carbon mitigation strategies, especially over the next decade or two. Projects that achieve this to sustain both nature and the livelihoods of the local community are invaluable to the transformation needed to thrive well beyond the climate crisis. Kudos to Amazon and The Nature Conservancy.”

Amazon’s initial investment in the Accelerator will support 3,000 farmers and restore approximately 20,000 hectares—a land mass approximately the size of the City of Seattle—within three years, removing up to 10 million metric tons of carbon dioxide from the atmosphere through 2050.

The Nature Conservancy will work together with the World Agroforestry Centre and several local civil society organizations to implement the Accelerator by helping small farmers restore degraded cattle pastures to native forest and agroforestry. The agroforestry systems will provide farmers with a sustainable source of income through the sale of cocoa and other crops. The Accelerator will also experiment with innovative ways to support farmers and nurture markets for sustainable forest-based commodities, including with digital technologies, and will advance new methodologies and satellite-based technologies for quantifying and monitoring carbon removal.

“Pará is home to 9% percent of the world’s tropical forest, but it’s facing unprecedented rates of deforestation, losing 3,300 acres every day in the last year,” said Jennifer Morris, CEO, The Nature Conservancy. “Over the last 13 years, small farms in Pará—an area where slash-and-burn agriculture can seem like the only option—were responsible for an average of 40% of the state’s deforestation. For 20 years, The Nature Conservancy has worked with small farmers, community leaders, government officials, and Indigenous peoples to identify and implement win-win solutions, like agroforestry, that help people and nature thrive. This new partnership with Amazon will allow us to provide the resources and technical assistance needed to advance this program and demonstrate that regenerative agroforestry and carbon markets are viable business models for communities in the Amazon.”

"We must join forces to achieve what may be the goal of the century: to develop our economies and safeguard people's income, while preserving and restoring the forest,” said Helder Barbalho, Governor of Pará. "The state of Pará is ready to tackle this challenge, and our strategy is clearly laid out in our Amazonia Agora plan, which commits us to being carbon free by 2036, through the reduction of deforestation and by promoting forest restoration. Investments, such as Amazon's, in sustainable agroforestry and reforestation in Pará are very welcome. This initiative will significantly benefit the state's community, natural resources, and biodiversity."

For more information on Amazon’s commitment to sustainability, visit: https://sustainability.aboutamazon.com.

About Amazon

Amazon is guided by four principles: Customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. Amazon strives to be Earth’s Most Customer-Centric Company, Earth’s Best Employer, and Earth’s Safest Place to Work. Customer reviews, 1-Click shopping, personalized recommendations, Prime, Fulfillment by Amazon, AWS, Kindle Direct Publishing, Kindle, Career Choice, Fire tablets, Fire TV, Amazon Echo, Alexa, Just Walk Out technology, Amazon Studios, and The Climate Pledge are some of the things pioneered by Amazon. For more information, visit amazon.com/about and follow @AmazonNews.

About The Nature Conservancy

The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world's toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters and oceans at an unprecedented scale, providing food and water sustainably and helping make cities more sustainable. Working in 72 countries and territories: 38 by direct conservation impact and 34 through partners, we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye